| 000 | 01847 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517164126.0 | ||
| 264 | 0 | _c20170926 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0181535 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShoukry, Heba Samy | |
| 245 | 0 | 0 |
_aProphylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity. _h[electronic resource] |
| 260 |
_bPloS one _c2017 |
||
| 300 |
_ae0181535 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCardiotoxicity _xdrug therapy |
| 650 | 0 | 4 |
_aCreatine Kinase, MB Form _xblood |
| 650 | 0 | 4 |
_aDoxorubicin _xtoxicity |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aEchocardiography |
| 650 | 0 | 4 |
_aHeart _xdiagnostic imaging |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aNFATC Transcription Factors _xmetabolism |
| 650 | 0 | 4 |
_aProtective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 |
_aStilbenes _xadministration & dosage |
| 700 | 1 | _aAmmar, Hania Ibrahim | |
| 700 | 1 | _aRashed, Laila Ahmed | |
| 700 | 1 | _aZikri, Maha Balegh | |
| 700 | 1 | _aShamaa, Ashraf Ali | |
| 700 | 1 | _aAbou Elfadl, Sahar Gamal | |
| 700 | 1 | _aRub, Ejlal Abu-Al | |
| 700 | 1 | _aSaravanan, Sekaran | |
| 700 | 1 | _aDhingra, Sanjiv | |
| 773 | 0 |
_tPloS one _gvol. 12 _gno. 7 _gp. e0181535 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0181535 _zAvailable from publisher's website |
| 999 |
_c27387027 _d27387027 |
||